Implications of interspecies signaling for virulence of bacterial and fungal pathogens

Future Microbiology

Volumn 6, Issue 7, 2011, Pages 799-817

  Holcombe, Lucy J ^a   O'Gara, Fergal ^a   Morrissey, John P ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

bacteria; fungus; infection; polymicrobial; signaling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

BACTERIAL VIRULENCE; BIOFILM; CANDIDA ALBICANS; CONFOCAL LASER MICROSCOPY; CYSTIC FIBROSIS; CYTOPLASM; FUNGAL VIRULENCE; GENE DELETION; GENE EXPRESSION; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENOME; HOSPITAL; INTRACELLULAR SIGNALING; LUNG; MICROBIAL COMMUNITY; MIXED INFECTION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULATORY MECHANISM; REVIEW; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; SPECIES; STREPTOCOCCUS GORDONII; SUPERNATANT; VIBRIO FISCHERI; WILD TYPE;

BACTERIA; COMMUNICABLE DISEASES; FUNGI; HUMANS; MICROBIAL INTERACTIONS; SIGNAL TRANSDUCTION; VIRULENCE;

BACTERIA (MICROORGANISMS); FUNGI;

EID: 79961042032     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.60     Document Type: Review

References (187)

1. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 59(4), 401-406 (2007). (Pubitemid 350184233)
2. Bauernfeind A, Bertele RM, Harms K et al. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 15(4), 270-277 (1987).
3. Burns JL, Van Dalfsen JM, Shawar RM et al. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J. Infect. Dis. 179(5), 1190-1196 (1999). (Pubitemid 29196500)
4. Gupta N, Haque A, Mukhopadhyay G, Narayan RP, Prasad R. Interactions between bacteria and Candida in the burn wound. Burns 31(3), 375-378 (2005). (Pubitemid 40363951)
5. Chotirmall SH, Greene CM, Mcelvaney NG. Candida species in cystic fibrosis: a road less travelled. Med. Mycol. 48(Suppl. 1), S114-S124 (2010).
6. Parahitiyawa NB, Scully C, Leung WK, Yam WC, Jin LJ, Samaranayake LP. Exploring the oral bacterial flora: current status and future directions. Oral Dis. 16(2), 136-145 (2010).
7. Ticac B, Ticac R, Rukavina T et al. Microbial colonization of tracheoesophageal voice prostheses (Provox2) following total laryngectomy. Eur. Arch. Otorhinolaryngol. 267(10), 1579-1586 (2010).
8. Leclair LW, Hogan DA. Mixed bacterial-fungal infections in the CF respiratory tract. Med. Mycol. 48(Suppl. 1), S125-S132 (2010).
9. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43(11), 5721-5732 (2005). (Pubitemid 41612354)
10. Duan K, Dammel C, Stein J, Rabin H, Surette MG. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol. Microbiol. 50(5), 1477-1491 (2003). (Pubitemid 38010446)
11. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr, Mylonakis E. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 105(38), 14585-14590 (2008).
12. Tampakakis E, Peleg AY, Mylonakis E. Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium. Eukaryot. Cell 8(5), 732-737 (2009).
13. De Sordi L, Muhlschlegel FA. Quorum sensing and fungal-bacterial interactions in Candida albicans: a communicative network regulating microbial coexistence and virulence. FEMS Yeast Res. 9(7), 990-999 (2009).
14. Peleg AY, Hogan DA, Mylonakis E. Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 8(5), 340-349 (2010).
15. Shank EA, Kolter R. New developments in microbial interspecies signaling. Curr. Opin. Microbiol. 12(2), 205-214 (2009).
16. Ruby EG. Lessons from a cooperative, bacterial-animal association: the Vibrio fischeri-Euprymna scolopes light organ symbiosis. Annu. Rev. Microbiol. 50, 591-624 (1996). (Pubitemid 26337475)
17. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacteriol. 185(7), 2080-2095 (2003). (Pubitemid 36363168)
18. Ng WL, Bassler BL. Bacterial quorum-sensing network architectures. Annu. Rev. Genet. 43, 197-222 (2009).
19. Fuqua C, Parsek MR, Greenberg EP. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu. Rev. Genet. 35, 439-468 (2001). (Pubitemid 34032983)
20. Williams P, Winzer K, Chan WC, Camara M. Look who's talking: communication and quorum sensing in the bacterial world. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 362(1483), 1119-1134 (2007). (Pubitemid 47075145)
21. Koch B, Liljefors T, Persson T, Nielsen J, Kjelleberg S, Givskov M. The LuxR receptor: the sites of interaction with quorum-sensing signals and inhibitors. Microbiology 151(Pt 11), 3589-3602 (2005). (Pubitemid 41632071)
22. Schaefer AL, Hanzelka BL, Eberhard A, Greenberg EP. Quorum sensing in Vibrio fischeri: probing autoinducer-LuxR interactions with autoinducer analogs. J. Bacteriol. 178(10), 2897-2901 (1996). (Pubitemid 26144048)
23. Zhang L, Murphy PJ, Kerr A, Tate ME. Agrobacterium conjugation and gene regulation by N-acyl-l-homoserine lactones. Nature 362(6419), 446-448 (1993). (Pubitemid 23107366)
24. Williams P, Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr. Opin. Microbiol. 12(2), 182-191 (2009).
25. Fouhy Y, Scanlon K, Schouest K et al. Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J. Bacteriol. 189(13), 4964-4968 (2007). (Pubitemid 47025610)
26. Boon C, Deng Y, Wang LH et al. A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. ISME J. 2(1), 27-36 (2008). (Pubitemid 351612352)
27. Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191(5), 1393-1403 (2009).
28. Deng Y, Wu J, Eberl L, Zhang LH. Structural and functional characterization of diffusible signal factor family quorum-sensing signals produced by members of the Burkholderia cepacia complex. Appl. Environ. Microbiol. 76(14), 4675-4683 (2010).
29. Wang LH, He Y, Gao Y et al. A bacterial cell-cell communication signal with cross-kingdom structural analogues. Mol. Microbiol. 51(3), 903-912 (2004). (Pubitemid 38233953)
30. Barber CE, Tang JL, Feng JX et al. A novel regulatory system required for pathogenicity of Xanthomonas campestris is mediated by a small diffusible signal molecule. Mol. Microbiol. 24(3), 555-566 (1997). (Pubitemid 27241703)
31. He YW, Wang C, Zhou L, Song H, Dow JM, Zhang LH. Dual signaling functions of the hybrid sensor kinase RpfC of Xanthomonas campestris involve either phosphorelay or receiver domain-protein interaction. J. Biol. Chem. 281(44), 33414-33421 (2006). (Pubitemid 46036722)
32. Ryan RP, Dow JM. Communication with a growing family: diffusible signal factor (DSF) signaling in bacteria. Trends Microbiol. 19(3), 145-152 (2011).
33. Vilchez R, Lemme A, Ballhausen B et al. Streptococcus mutans inhibits Candida albicans hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF). Chembiochem. 11(11), 1552-1562 (2010).
34. Pesci EC, Milbank JB, Pearson JP et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 96(20), 11229-11234 (1999). (Pubitemid 29487363)
35. Heeb S, Fletcher MP, Chhabra SR, Diggle SP, Williams P, Camara M. Quinolones: from antibiotics to autoinducers. FEMS Microbiol. Rev. 35(2), 247-274 (2011).
36. Dekimpe V, Deziel E. Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. Microbiology 155(Pt 3), 712-723 (2009).
37. Duan K, Surette MG. Environmental regulation of Pseudomonas aeruginosa PAO1 Las and Rhl quorum-sensing systems. J. Bacteriol. 189(13), 4827-4836 (2007). (Pubitemid 47025595)
38. Krell T, Lacal J, Busch A, Silva-Jimenez H, Guazzaroni ME, Ramos JL. Bacterial sensor kinases: diversity in the recognition of environmental signals. Annu. Rev. Microbiol. 64, 539-559 (2010).
39. Lopez D, Vlamakis H, Kolter R. Generation of multiple cell types in Bacillus subtilis. FEMS Microbiol. Rev. 33(1), 152-163 (2009).
40. Lyon GJ, Novick RP. Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 25(9), 1389-1403 (2004). (Pubitemid 39221523)
41. Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu. Rev. Genet. 42, 541-564 (2008).
42. Rocha-Estrada J, Aceves-Diez AE, Guarneros G, De La Torre M. The RNPP family of quorum-sensing proteins in Gram-positive bacteria. Appl. Microbiol. Biotechnol. 87(3), 913-923 (2010).
43. Henke JM, Bassler BL. Quorum sensing regulates type III secretion in Vibrio harveyi and Vibrio parahaemolyticus. J. Bacteriol. 186(12), 3794-3805 (2004). (Pubitemid 38746055)
44. Bassler BL, Wright M, Silverman MR. Multiple signalling systems controlling expression of luminescence in Vibrio harveyi: sequence and function of genes encoding a second sensory pathway. Mol. Microbiol. 13(2), 273-286 (1994). (Pubitemid 24225499)
45. Schauder S, Shokat K, Surette MG, Bassler BL. The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol. Microbiol. 41(2), 463-476 (2001). (Pubitemid 32730544)
46. Chen X, Schauder S, Potier N et al. Structural identification of a bacterial quorum-sensing signal containing boron. Nature 415(6871), 545-549 (2002). (Pubitemid 34130611)
47. Federle MJ. Autoinducer-2-based chemical communication in bacteria: complexities of interspecies signaling. Contrib. Microbiol. 16, 18-32 (2009).
48. Novak EA, Shao H, Daep CA, Demuth DR. Autoinducer-2 and QseC control biofilm formation and in vivo virulence of Aggregatibacter actinomycetemcomitans. Infect. Immun. 78(7), 2919-2926 (2010).
49. Zhao L, Xue T, Shang F, Sun H, Sun B. Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence. Infect. Immun. 78(8), 3506-3515 (2010).
50. Holmes K, Tavender TJ, Winzer K, Wells JM, Hardie KR. AI-2 does not function as a quorum sensing molecule in Campylobacter jejuni during exponential growth in vitro. BMC Microbiol. 9, 214 (2009).
51. Jakubovics NS. Talk of the town: interspecies communication in oral biofilms. Mol. Oral Microbiol. 25(1), 4-14 (2010).
52. Reading NC, Torres AG, Kendall MM, Hughes DT, Yamamoto K, Sperandio V. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J. Bacteriol. 189(6), 2468-2476 (2007). (Pubitemid 46411361)
53. Reading NC, Rasko D, Torres AG, Sperandio V. A transcriptome study of the QseEF two-component system and the QseG membrane protein in enterohaemorrhagic Escherichia coli O157 : H7. Microbiology 156(Pt 4), 1167-1175 (2009).
54. Sperandio V, Li CC, Kaper JB. Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in enterohemorrhagic E. coli. Infect. Immun. 70(6), 3085-3093 (2002). (Pubitemid 34564171)
55. Sperandio V, Mellies JL, Delahay RM et al. Activation of enteropathogenic Escherichia coli (EPEC) LEE2 and LEE3 operons by Ler. Mol. Microbiol. 38(4), 781-793 (2000).
56. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. Bacteria-host communication: the language of hormones. Proc. Natl Acad. Sci. USA 100(15), 8951-8956 (2003). (Pubitemid 36899204)
57. Sperandio V, Torres AG, Kaper JB. Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol. Microbiol. 43(3), 809-821 (2002). (Pubitemid 34597272)
58. Hughes DT, Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 6(2), 111-120 (2008).
59. Whiteway M, Bachewich C. Morphogenesis in Candida albicans. Annu. Rev. Microbiol. 61, 529-553 (2007). (Pubitemid 350058220)
60. Kruppa M. Quorum sensing and Candida albicans. Mycoses 52(1), 1-10 (2009).
61. Hornby JM, Nickerson KW. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob. Agents Chemother. 48(6), 2305-2307 (2004). (Pubitemid 38691638)
62. Alem MA, Oteef MD, Flowers TH, Douglas LJ. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot. Cell 5(10), 1770-1779 (2006). (Pubitemid 44622603)
63. Chen H, Fujita M, Feng Q, Clardy J, Fink GR. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc. Natl Acad. Sci. USA 101(14), 5048-5052 (2004). (Pubitemid 38469200)
64. Nigam S, Ciccoli R, Ivanov I, Sczepanski M, Deva R. On mechanism of quorum sensing in Candida albicans by 3(R)-hydroxy-tetradecaenoic acid. Curr. Microbiol. 62(1), 55-63 (2011).
65. Singh A, Del Poeta M. Lipid signalling in pathogenic fungi. Cell. Microbiol. 13(2), 177-185 (2011).
66. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68(11), 5459-5463 (2002). (Pubitemid 35265681)
67. Weber K, Schulz B, Ruhnke M. The quorum-sensing molecule E,E-farnesol-its variable secretion and its impact on the growth and metabolism of Candida species. Yeast 27(9), 727-739 (2010).
68. Shirtliff ME, Krom BP, Meijering RA et al. Farnesol-induced apoptosis in Candida albicans. Antimicrob. Agents Chemother. 53(6), 2392-2401 (2009).
69. Westwater C, Balish E, Schofield DA. Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot. Cell. 4(10), 1654-1661 (2005). (Pubitemid 41484225)
70. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol. Microbiol. 67(1), 47-62 (2008). (Pubitemid 350231134)
71. Kebaara BW, Langford ML, Navarathna DH, Dumitru R, Nickerson KW, Atkin AL. Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction. Eukaryot. Cell 7(6), 980-987 (2008). (Pubitemid 351961577)
72. Hogan DA, Sundstrom P. The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans. Future Microbiol. 4(10), 1263-1270 (2009).
73. Giacometti R, Kronberg F, Biondi RM, Passeron S. Catalytic isoforms Tpk1 and Tpk2 of Candida albicans PKA have non-redundant roles in stress response and glycogen storage. Yeast 26(5), 273-285 (2009).
74. Giacometti R, Kronberg F, Biondi RM, Passeron S. Candida albicans Tpk1p and Tpk2p isoforms differentially regulate pseudohyphal development, biofilm structure, cell aggregation and adhesins expression. Yeast 28(4), 293-308 (2010).
75. Deveau A, Piispanen AE, Jackson AA, Hogan DA. Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the Ras-cyclic AMP signaling pathway. Eukaryot. Cell 9(4), 569-577 (2010).
76. Kruppa M, Krom BP, Chauhan N, Bambach AV, Cihlar RL, Calderone RA. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot. Cell 3(4), 1062-1065 (2004). (Pubitemid 39098881)
77. Dichtl K, Ebel F, Dirr F, Routier FH, Heesemann J, Wagener J. Farnesol misplaces tip-localized Rho proteins and inhibits cell wall integrity signalling in Aspergillus fumigatus. Mol. Microbiol. 76(5), 1191-1204 (2010).
78. Hall RA, Muhlschlegel FA. A multi-protein complex controls cAMP signalling and filamentation in the fungal pathogen Candida albicans. Mol. Microbiol. 75(3), 534-537 (2010).
79. Zou H, Fang HM, Zhu Y, Wang Y. Candida albicans Cyr1, Cap1 and G-actin form a sensor/effector apparatus for activating cAMP synthesis in hyphal growth. Mol. Microbiol. 75(3), 579-591 (2010).
80. Weber K, Sohr R, Schulz B, Fleischhacker M, Ruhnke M. Secretion of E,E-farnesol and biofilm formation in eight different Candida species. Antimicrob. Agents Chemother. 52(5), 1859-1861 (2008). (Pubitemid 351614688)
81. Kolenbrander PE, Palmer RJ Jr, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 8(7), 471-480 (2010).
82. Zijnge V, Van Leeuwen MB, Degener JE et al. Oral biofilm architecture on natural teeth. PLoS One 5(2), E9321 (2010).
83. Palmer RJ Jr, Gordon SM, Cisar JO, Kolenbrander PE. Coaggregation- mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J. Bacteriol. 185(11), 3400-3409 (2003). (Pubitemid 36617753)
84. Palmer RJ Jr, Kazmerzak K, Hansen MC, Kolenbrander PE. Mutualism versus independence: strategies of mixed-species oral biofilms in vitro using saliva as the sole nutrient source. Infect. Immun. 69(9), 5794-5804 (2001). (Pubitemid 32786519)
85. Jenkinson HF, Lala HC, Shepherd MG. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect. Immun. 58(5), 1429-1436 (1990). (Pubitemid 20151811)
86. O'Sullivan JM, Jenkinson HF, Cannon RD. Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology 146(Pt 1), 41-48 (2000). (Pubitemid 30066305)
87. Nobbs AH, Vickerman MM, Jenkinson HF. Heterologous expression of Candida albicans cell wall-associated adhesins in Saccharomyces cerevisiae reveals differential specificities in adherence and biofilm formation and in binding oral Streptococcus gordonii. Eukaryot. Cell 9(10), 1622-1634 (2010).
88. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect. Immun. 78(11), 4644-4652 (2010).
89. Rickard AH, Campagna SR, Kolenbrander PE. Autoinducer-2 is produced in saliva-fed flow conditions relevant to natural oral biofilms. J. Appl. Microbiol. 105(6), 2096-2103 (2008).
90. Rickard AH, Palmer RJ Jr, Blehert DS et al. Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilm growth. Mol. Microbiol. 60(6), 1446-1456 (2006). (Pubitemid 43801436)
91. Bamford CV, D'Mello A, Nobbs AH, Dutton LC, Vickerman MM, Jenkinson HF. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun. 77(9), 3696-3704 (2009).
92. Nasution O, Srinivasa K, Kim M et al. Hydrogen peroxide induces hyphal differentiation in Candida albicans. Eukaryot. Cell 7(11), 2008-2011 (2008).
93. Jarosz LM, Deng DM, Van Der Mei HC, Crielaard W, Krom BP. Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot. Cell 8(11), 1658-1664 (2009).
94. Joyner PM, Liu J, Zhang Z, Merritt J, Qi F, Cichewicz RH. Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org. Biomol. Chem. 8(24), 5486-5489 (2010).
95. Distler W, Kroncke A. Acid formation by mixed cultures of dental plaque bacteria Actinomyces and Veillonella. Arch. Oral. Biol. 26(2), 123-126 (1981). (Pubitemid 11097674)
96. Egland PG, Palmer RJ Jr, Kolenbrander PE. Interspecies communication in Streptococcus gordonii-Veillonella atypica biofilms: signaling in flow conditions requires juxtaposition. Proc. Natl Acad. Sci. USA 101(48), 16917-16922 (2004). (Pubitemid 39601339)
97. Johnson BP, Jensen BJ, Ransom EM et al. Interspecies signaling between Veillonella atypica and Streptococcus gordonii requires the transcription factor CcpA. J. Bacteriol. 191(17), 5563-5565 (2009).
98. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 153(Pt 4), 917-923 (2007). (Pubitemid 46605791)
99. Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J. Infect. 28(3), 305-310 (1994). (Pubitemid 24158722)
100. Kerr JR. Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J. Clin. Microbiol. 32(2), 525-527 (1994). (Pubitemid 24033926)
101. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296(5576), 2229-2232 (2002). (Pubitemid 34680309)
102. Brand A, Barnes JD, Mackenzie KS, Odds FC, Gow NA. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 287(1), 48-55 (2008).
103. Gibson J, Sood A, Hogan DA. Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 75(2), 504-513 (2009).
104. Kerr JR, Taylor GW, Rutman A, Hoiby N, Cole PJ, Wilson R. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52(5), 385-387 (1999). (Pubitemid 29200034)
105. Morales DK, Jacobs NJ, Rajamani S, Krishnamurthy M, Cubillos-Ruiz JR, Hogan DA. Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms. Mol. Microbiol. 78(6), 1379-1392 (2010).
106. Riley MA, Wertz JE. Bacteriocins: evolution, ecology, and application. Annu. Rev. Microbiol. 56, 117-137 (2002). (Pubitemid 35217450)
107. Bakkal S, Robinson SM, Ordonez CL, Waltz DA, Riley MA. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 156(Pt 7), 2058-2067 (2010).
108. Hoffman LR, Deziel E, D'Argenio DA et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 103(52), 19890-19895 (2006). (Pubitemid 46037526)
109. Lepine F, Milot S, Deziel E, He J, Rahme LG. Electrospray/mass spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs) produced by Pseudomonas aeruginosa. J. Am. Soc. Mass Spectrom. 15(6), 862-869 (2004). (Pubitemid 38624234)
110. Geisenberger O, Givskov M, Riedel K, Hoiby N, Tummler B, Eberl L. Production of N-acyl-l-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis. FEMS Microbiol. Lett. 184(2), 273-278 (2000). (Pubitemid 30125352)
111. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280(5361), 295-298 (1998). (Pubitemid 28178075)
112. Huber B, Riedel K, Hentzer M et al. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147(Pt 9), 2517-2528 (2001). (Pubitemid 32899247)
113. Parsek MR, Greenberg EP. Quorum sensing signals in development of Pseudomonas aeruginosa biofilms. Methods Enzymol. 310, 43-55 (1999). (Pubitemid 29504267)
114. Lewenza S, Visser MB, Sokol PA. Interspecies communication between Burkholderia cepacia and Pseudomonas aeruginosa. Can. J. Microbiol. 48(8), 707-716 (2002). (Pubitemid 35370786)
115. Mckenney D, Brown KE, Allison DG. Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J. Bacteriol. 177(23), 6989-6992 (1995).
116. Riedel K, Hentzer M, Geisenberger O et al. N-acylhomoserine-lactone- mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147(Pt 12), 3249-3262 (2001). (Pubitemid 33150331)
117. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 54(5), 1212-1223 (2004). (Pubitemid 39578266)
118. McAlester G, O'Gara F, Morrissey JP. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J. Med. Microbiol. 57(Pt 5), 563-569 (2008). (Pubitemid 351632902)
119. Ryan RP, Fouhy Y, Garcia Bf et al. Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa. Mol. Microbiol. 68(1), 75-86 (2008). (Pubitemid 351363777)
120. Cugini C, Morales DK, Hogan DA. Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasR-defective Pseudomonas aeruginosa strains. Microbiology 156(Pt 10), 3096-3107 (2010).
121. Cugini C, Calfee MW, Farrow JM 3rd, Morales DK, Pesci EC, Hogan DA. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol. 65(4), 896-906 (2007). (Pubitemid 47221077)
122. Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob. Agents Chemother. 50(4), 1463-1469 (2006).
123. Kuroda M, Nagasaki S, Ito R, Ohta T. Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus. FEMS Microbiol. Lett. 273(1), 28-34 (2007). (Pubitemid 47024886)
124. Akagawa G, Abe S, Yamaguchi H. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J. Infect. Dis. 171(6), 1539-1544 (1995).
125. Burd RS, Raymond CS, Dunn DL. Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. J. Surg. Res. 52(6), 537-542 (1992).
126. Gale D, Sandoval B. Response of mice to the inoculations of both Candida albicans and Escherichia coli. I. The enhancement phenomenon. J. Bacteriol. 73(5), 616-624 (1957).
127. Klaerner HG, Uknis ME, Acton RD, Dahlberg PS, Carlone-Jambor C, Dunn DL. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. J. Surg. Res. 70(2), 161-165 (1997). (Pubitemid 27315201)
128. Xu XL, Lee RT, Fang HM et al. Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe 4(1), 28-39 (2008). (Pubitemid 351958113)
129. Piispanen AE, Hogan DA. PEPped up: induction of Candida albicans virulence by bacterial cell wall fragments. Cell Host Microbe 4(1), 1-2 (2008). (Pubitemid 351944056)
130. Boris S, Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2(5), 543-546 (2000). (Pubitemid 30387208)
131. Fitzsimmons N, Berry DR. Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system. Microbios 80(323), 125-133 (1994).
132. Gudina EJ, Rocha V, Teixeira JA, Rodrigues LR. Antimicrobial and antiadhesive properties of a biosurfactant isolated from Lactobacillus paracasei ssp. paracasei A20. Lett. Appl. Microbiol. 50(4), 419-424 (2010).
133. Velraeds MM, Van De Belt-Gritter B, Van Der Mei HC, Reid G, Busscher HJ. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J. Med. Microbiol. 47(12), 1081-1085 (1998). (Pubitemid 28534829)
134. Martinez RC, Seney SL, Summers KL, Nomizo A, De Martinis EC, Reid G. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol. Immunol. 53(9), 487-495 (2009).
135. Spear GT, Zariffard MR, Cohen MH, Sha BE. Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J. Reprod. Immunol. 78(1), 76-79 (2008).
136. Bhargava N, Sharma P, Capalash N. Quorum sensing in Acinetobacter: an emerging pathogen. Crit. Rev. Microbiol. 36(4), 349-360 (2010).
137. Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 77(8), 3150-3160 (2009).
138. Rickard AH, Colacino KR, Manton KM et al. Production of cell-cell signalling molecules by bacteria isolated from human chronic wounds. J. Appl. Microbiol. 108(5), 1509-1522 (2010).
139. Kania RE, Lamers GE, Van De Laar N et al. Biofilms on tracheoesophageal voice prostheses: a confocal laser scanning microscopy demonstration of mixed bacterial and yeast biofilms. Biofouling 26(5), 519-526 (2010).
140. Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development. BMC Microbiol. 10, 125 (2010).
141. Mowat E, Rajendran R, Williams C et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol. Lett. 313(2), 96-102 (2010).
142. Holcombe LJ, McAlester G, Munro CA et al. Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans. Microbiology 156(Pt 5), 1476-1486 (2010).
143. Bandara HM, Lam OL, Watt RM, Jin LJ, Samaranayake LP. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species. J. Med. Microbiol. 59(Pt 10), 1225-1234 (2010).
144. Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J. Med. Microbiol. 58(Pt 12), 1623-1631 (2009).
145. Schaller M, Weindl G. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia for the study of host-pathogen interactions. Methods Mol. Biol. 470, 327-345 (2009).
146. Schaller M, Zakikhany K, Naglik JR, Weindl G, Hube B. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia. Nat. Protoc. 1(6), 2767-2773 (2006).
147. Riedel K, Hentzer M, Geisenberger O et al. N-acylhomoserine-lactone- mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147(Pt 12), 3249-3262 (2001). (Pubitemid 33150331)
148. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72(10), 6023-6031 (2004). (Pubitemid 39303717)
149. Martinez LR, Mihu MR, Tar M et al. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. J. Infect. Dis. 201(9), 1436-1440 (2010).
150. Vial L, Deziel E. The fruit fly as a meeting place for microbes. Cell Host Microbe 4(6), 505-507 (2008). (Pubitemid 352762962)
151. Roux D, Gaudry S, Dreyfuss D et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit. Care Med. 37(3), 1062-1067 (2009).
152. Pacheco AR, Sperandio V. Inter-kingdom signaling: chemical language between bacteria and host. Curr. Opin. Microbiol. 12(2), 192-198 (2009).
153. Shiner EK, Rumbaugh KP, Williams SC. Inter-kingdom signaling: deciphering the language of acyl homoserine lactones. FEMS Microbiol. Rev. 29(5), 935-947 (2005). (Pubitemid 41416844)
154. Kalia VC, Purohit HJ. Quenching the quorum sensing system: potential antibacterial drug targets. Crit. Rev. Microbiol. 37(2), 121-140 (2011).
155. Kolter R. Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology. Int. Microbiol. 13(1), 1-7 (2010).
156. Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol. Med. Microbiol. 59(3), 227-238 (2010).
157. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol. Med. Microbiol. 59(3), 253-268 (2010).
158. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6(3), 199-210 (2008). (Pubitemid 351256315)
159. Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 5(6), 917-933 (2010).
160. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell. Microbiol. 11(7), 1034-1043 (2009).
161. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35(4), 340-355 (2009).
162. Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 9(2), 109-118 (2011).
163. Wang Y, Zou H, Fang HM, Zhu Y. Linking cellular actin status with cAMP signaling in Candida albicans. Virulence 1(3), 202-205 (2010).
164. Hall RA, De Sordi L, Maccallum DM et al. CO(2) acts as a signalling molecule in populations of the fungal pathogen Candida albicans. PLoS Pathog. 6(11), E1001193 (2010).
165. Chung SC, Kim TI, Ahn CH, Shin J, Oh KB. Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid. FEBS Lett. 584(22), 4639-4645 (2010).
166. Sifri CD, Begun J, Ausubel FM. The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13(3), 119-127 (2005). (Pubitemid 40311894)
167. Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol. 10(1), 47-58 (2010).
168. Darby C, Cosma CL, Thomas JH, Manoil C. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 96(26), 15202-15207 (1999). (Pubitemid 30019789)
169. Mahajan-Miklos S, Rahme LG, Ausubel FM. Elucidating the molecular mechanisms of bacterial virulence using non-mammalian hosts. Mol. Microbiol. 37(5), 981-988 (2000).
170. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96(1), 47-56 (1999). (Pubitemid 29044152)
171. Tan MW, Mahajan-Miklos S, Ausubel FM. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad. Sci. USA 96(2), 715-720 (1999). (Pubitemid 29061274)
172. Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc. Natl Acad. Sci. USA 96(5), 2408-2413 (1999). (Pubitemid 29117928)
173. Aballay A, Yorgey P, Ausubel FM. Salmonella Typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr. Biol. 10(23), 1539-1542 (2000). (Pubitemid 32003649)
174. Couillault C, Ewbank JJ. Diverse bacteria are pathogens of Caenorhabditis elegans. Infect. Immun. 70(8), 4705-4707 (2002). (Pubitemid 34790988)
175. Garsin DA, Sifri CD, Mylonakis E et al. A simple model host for identifying Gram-positive virulence factors. Proc. Natl Acad. Sci. USA 98(19), 10892-10897 (2001). (Pubitemid 32878715)
176. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 3(2), E18 (2007).
177. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl Acad. Sci. USA 99(24), 15675-15680 (2002). (Pubitemid 35403990)
178. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot. Cell 8(11), 1750-1758 (2009).
179. Wang C, Wang J, Gong J et al. Use of Caenorhabditis elegans for preselecting Lactobacillus isolates to control Salmonella Typhimurium. J. Food Prot. 74(1), 86-93 (2011).
180. Moy TI, Conery AL, Larkins-Ford J et al. High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem. Biol. 4(7), 527-533 (2009).
181. Beale E, Li G, Tan MW, Rumbaugh KP. Caenorhabditis elegans senses bacterial autoinducers. Appl. Environ. Microbiol. 72(7), 5135-5137 (2006). (Pubitemid 44078856)
182. Bogaerts A, Beets I, Temmerman L, Schoofs L, Verleyen P. Proteome changes of Caenorhabditis elegans upon a Staphylococcus aureus infection. Biol. Direct 5, 11 (2010).
183. Garvis S, Munder A, Ball G et al. Caenorhabditis elegans semi-automated liquid screen reveals a specialized role for the chemotaxis gene cheB2 in Pseudomonas aeruginosa virulence. PLoS Pathog. 5(8), E1000540 (2009).
184. Mellies JL, Lawrence-Pine ER. Interkingdom signaling between pathogenic bacteria and Caenorhabditis elegans. Trends Microbiol. 18(10), 448-454 (2010).
185. Papaioannou E, Wahjudi M, Nadal-Jimenez P, Koch G, Setroikromo R, Quax WJ. Quorum-quenching acylase reduces the virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans infection model. Antimicrob. Agents Chemother. 53(11), 4891-4897 (2009).
186. Swem LR, Swem DL, O'Loughlin CT et al. A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol. Cell 35(2), 143-153 (2009).
187. Wopperer J, Cardona ST, Huber B, Jacobi CA, Valvano MA, Eberl L. A quorum-quenching approach to investigate the conservation of quorum-sensing-regulated functions within the Burkholderia cepacia complex. Appl. Environ. Microbiol. 72(2), 1579-1587 (2006). (Pubitemid 43271273)